Replies to post #212708 on Biotech Values

[DewDiligence]

TTPH—Eravacycline phase-3 fails to show non-inferiority to Ertapenem in urinary-tract infections:

https://finance.yahoo.com/news/tetraphase-announces-top-line-results-210100172.html

CC at 4:30pm ET.